Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

IntroductionLong-chain omega-3 polyunsaturated fatty acids (OM3 PUFA) are commonly used for cardiovascular disease prevention. High-dose eicosapentaenoic acid (EPA) is reported to reduce major adverse cardiovascular events (MACE); however, a combined EPA and docosahexaenoic acid (DHA) supplementatio...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Viet T. Le, Stacey Knight, Jeramie D. Watrous, Mahan Najhawan, Khoi Dao, Raymond O. McCubrey, Tami L. Bair, Benjamin D. Horne, Heidi T. May, Joseph B. Muhlestein, John R. Nelson, John F. Carlquist, Kirk U. Knowlton, Mohit Jain, Jeffrey L. Anderson
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-08-01
Serija:	Frontiers in Cardiovascular Medicine
Teme:	EPA DHA major adverse cardiovascular events omega-3 outcomes
Online dostop:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1229130/full
Oznake:	Označite Brez oznak, prvi označite!